EMS, officially known as EMS S/A, is a leading Brazilian pharmaceutical company headquartered in Jaguariúna, São Paulo. Founded in 1964, EMS has established itself as a key player in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic and branded medications. With a strong presence across Brazil and significant operations in Latin America, EMS has achieved notable milestones, including becoming one of the largest pharmaceutical companies in Brazil. The company is renowned for its extensive portfolio of high-quality products, which includes prescription medications, over-the-counter drugs, and a variety of therapeutic classes. EMS distinguishes itself through its commitment to innovation and quality, ensuring that its offerings meet the highest industry standards. With a robust market position, EMS continues to contribute significantly to the healthcare sector, making it a trusted name among healthcare professionals and patients alike.
How does EMS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
EMS's score of 32 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, EMS, headquartered in Brazil, reported total carbon emissions of approximately 22,000,000 kg CO2e. This figure includes 18,242,150 kg CO2e from Scope 1 emissions, 3,668,750 kg CO2e from Scope 2 emissions, and 3,771,590 kg CO2e from Scope 3 emissions. The data is cascaded from its parent company, EMS S.A., reflecting the emissions profile of the current subsidiary. Despite the significant emissions reported, EMS has not established specific reduction targets or climate pledges as part of its sustainability initiatives. The absence of formal commitments indicates a potential area for growth in their climate strategy. As a part of the broader industry context, EMS's emissions data highlights the importance of transparency and accountability in corporate climate commitments, particularly as global pressure mounts for companies to reduce their carbon footprints.
Access structured emissions data, company-specific emission factors, and source documents
2022 | |
---|---|
Scope 1 | 18,242,150 |
Scope 2 | 3,668,750 |
Scope 3 | 3,771,590 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
EMS is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.